Medtronic

This study is monitoring the long-term safety of a special drug-coated balloon used to open blocked blood vessels in the arm that are used for dialysis. It will follow 240 patients for five years to track serious infections and other health events. The study is required by the FD…

This study is observing how well a special feature in heart devices works to control dangerously fast heart rhythms. The feature tries to stop these rhythms with gentle electrical pulses instead of painful shocks. Researchers are following 2,200 patients who already have these de…

This study is tracking the long-term safety and performance of the Micra wireless pacemaker in real-world patients. It will follow 3,100 people who receive the device for at least 9 years to monitor for any complications and see how well it works over time. The goal is to confirm…

This study is monitoring the long-term safety and performance of a specific heart defibrillator lead (the OmniaSecure™) after it has been approved for sale. It will follow 2,000 patients who have this device implanted to treat dangerously fast heart rhythms. Researchers will trac…

This study is observing how well a specific feature in certain Medtronic heart devices works to predict worsening heart failure in real-world settings. It involves 2,200 patients who already have these implanted devices and are being monitored remotely. The research aims to see h…

This study follows patients who have already received a specific heart failure device lead to monitor its long-term safety and performance in real-world use. Researchers will track over 1,000 patients for up to five years to see how well the device lead holds up over time. The st…

This study aims to gather real-world evidence on the safety and effectiveness of the Micra leadless pacemaker, a small device implanted in the heart to treat slow heart rhythms. It will analyze the health insurance claims of 37,000 Medicare patients to track complication rates an…

This study aims to collect real-world safety and effectiveness data on the Micra AV, a small, leadless pacemaker, as required by Medicare. It will analyze the health insurance claims of 37,000 Medicare patients who received either the Micra AV or a traditional pacemaker. The main…